B2S Life Sciences

Business overview

B2S Life Sciences describes itself as a biotherapeutic enablement company. Its website says it combines custom critical reagents with regulated bioanalysis to support biotherapeutic drug candidates and diagnostics. Source ↗

Products & services

• The company lists custom reagent development and life-cycle management, assay development and qualification, and GLP sample analysis among its laboratory services. Its listed capabilities also include cell culture, neutralizing antibody assays, and biotherapeutic CMC support. Source ↗
• B2S lists data analytics and writing services, including immunoassay validation, statistical analysis, clinical immunogenicity reports, and nonclinical and clinical data analysis. Its consulting services include management of bioanalytical projects at contract research organizations and PK/TK data analysis. Source ↗

Customers & markets

The company says its services are intended for pharmaceutical, biotechnology, contract research, and diagnostic companies. Its website also describes its work as supporting clients’ biotherapeutic research and development needs. Source ↗

Company background

The company’s history page says Bowsher, Brunelle and Smith, LLC, doing business as B2S Consulting, was founded in 2003 to provide bioanalytical and statistical services for drug research and development. A new LLC was founded in early 2014 and rebranded as B2S Life Sciences, LLC. Source ↗

The company’s timeline says it began business focused on critical reagents and data analytics in 2016, then initiated assay development activities in 2018. It also reports signing its 100th client in early 2022. Source ↗

Indiana connection

B2S Life Sciences’ website reports that it purchased a historic building in Franklin, Indiana, in 2015 and began renovations. It says the renovations were completed late in 2019, with a facility open house held that year. Source ↗